Objectives. The aim of this study was to characterize fully in vivo aortic
compliance over a wide range of passive distending pressures, and to study
pharmacologically induced alterations in compliance using an intravascular
ultrasound-based technique in the canine model of heart failure.
Background. Altered aortic compliance may influence considerably the functi
on of the failing heart. Although some studies demonstrate that patients vi
ith heart failure have decreased aortic compliance, data from other studies
are conflicting.
Methods. Aortic pressures and dimensions in seven dogs were determined both
before and after pacing-induced congestive heart failure (CHF) using simul
taneous micromanometer and intravascular ultrasound transducers. Decreases
in aortic pressure were produced at baseline and after nitroprusside and do
butamine infusions. Inner and outer aortic circumferences were drawn at the
lumen-intimal and media-adventitial borders.
Results. Aortic pressure-dimension (chamber) stiffness constants were great
er after heart failure was produced (10.0 +/- 1.5 vs. 6.7 +/- 1.5, p < 0.05
), but stress-strain stiffness (material) constants were similar (11.4 +/-
1.8 vs. 11.3 +/- 1.0, p = NS). Equivasodilating doses of nitroprusside and
10 mu g/kg/min dobutamine decreased pressure-dimension stiffness constants
after pacing-induced heart failure but not beforehand. The aortic wall thic
kness to diameter ratio was significantly greater in CHF than in the contro
l condition (0.30 +/- 0.08 vs. 0.16 +/- 0.03, p < 0.01).
Conclusions. Aortic compliance is decreased in this model of CHF, and this
change is attributable primarily to vessel geometry rather than material pr
operties. Equivasodilating doses of nitroprusside and equivalent doses of d
obutamine increase aortic chamber compliance in dogs with CHF, but not in n
ormal dogs. These data suggest that the beneficial effects of nitroprusside
and dobutamine in CHF occur in part from improvement in aortic compliance.
(C) 1998 by the American College of Cardiology.